GlassScriptPhysician profile
Harry L Cheves
NPI 1063491504
$4,654.20
in general payments reported to CMS, 2019-2025
40 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $836 · 2020: $625 · 2021: $718 · 2022: $662 · 2023: $632 · 2024: $689 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $757.15 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $722.31 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $514.73 | 2019-2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $309.82 | 2019-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $204.45 | 2019-2025 | Ubrelvy |
| Esperion Therapeutics, INC. | $193.13 | 2020-2025 | Nexletol |
| Pfizer INC. | $143.00 | 2019-2025 | |
| Amarin Pharma, INC. | $138.82 | 2019-2021 | |
| Eisai INC. | $128.49 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $119.08 | 2019-2021 | |
| Medtronic, INC. | $118.81 | 2022-2024 | Minimed 780g |
| Abbott Laboratories | $108.89 | 2023-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Currax Pharmaceuticals LLC | $104.25 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $84.74 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $79.73 | 2021-2024 | Camzyos, Eliquis |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Cheves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.